Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations
Authors:
- Dennis C. TurkDTDennis C. Turk
- Richard DartRDRichard Dart
- 1 October 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Pain
- Vol. 153 (10) , 1997-2008
Abstract
Opioids are essential to the management of pain in many patients, but they also are associated with potential risks for abuse, overdose, and diversion. A number of efforts have been devoted to the development of abuse-deterrent formulations of opioids to reduce these risks. This article summarizes a consensus meeting that was organized to propose recommendations for the types of clinical studies that can be used to assess the abuse deterrence of different opioid formulations. Because of the many types of individuals who may be exposed to opioids, an opioid formulation will need to be studied in several populations using various study designs to determine its abuse-deterrent capabilities. It is recommended that the research conducted to evaluate abuse deterrence should include studies assessing: (1) abuse liability, (2) the likelihood that opioid abusers will find methods to circumvent the deterrent properties of the formulation, (3) measures of misuse and abuse in randomized clinical trials involving pain patients with both low risk and high risk of abuse, and (4) postmarketing epidemiological studies.Keywords
This publication has 69 references indexed in Scilit:
- Characteristics of Opioid Prescriptions in 2009JAMA, 2011
- Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP StudyPain, 2010
- Principles of laboratory assessment of drug abuse liability and implications for clinical developmentDrug and Alcohol Dependence, 2009
- Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related ConditionsDrug and Alcohol Dependence, 2009
- Correlates of extramedical use of OxyContin® versus other analgesic opioids among the US general populationDrug and Alcohol Dependence, 2009
- Addressing the intersecting problems of opioid misuse and chronic pain treatment.Experimental and Clinical Psychopharmacology, 2008
- Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study.Experimental and Clinical Psychopharmacology, 2008
- The role of human drug self-administration procedures in the development of medicationsDrug and Alcohol Dependence, 2008
- Validation of the Revised Screener and Opioid Assessment for Patients With Pain (SOAPP-R)The Journal of Pain, 2008
- Development and validation of the Current Opioid Misuse MeasurePain, 2007